MedPath

Effect of Microrelin on the size of uterus fibroma in patients undergoing hysteroscopic myoma resectio

Phase 3
Conditions
eiomyoma of uterus.
Leiomyoma of uterus
Registration Number
IRCT201408133950N3
Lead Sponsor
Vice Chancellor for Research of Tehran University of Medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Inclusion Criteria: Be a pre-menopausal woman between 18 and 50 years, have indication of surgical myomectomy due to any complain, Less than 2 myomas with the diameter of 2- 4 Cm which are totally intracavitary or have a myometrial expansion less than 50%, If of childbearing potential the subject must be practicing a non-hormonal method of contraception, BMI = 18 and = 40.

Exclusion Criteria

Indication of emergent surgery, history of or current uterine cervical, ovarian or breast cancer, current endometrium atypical hyperplasia or adenocarcinoma, a known severe coagulation disorder, has a history of or current treatment for myoma with a Selective Progesterone Receptor Modulator (SPRM) or a GnRH-agonist,Has a history of or known current osteoporosis, abnormal hepatic function at study entry, a positive pregnancy test at baseline or is nursing or planning a pregnancy during the course of the study, a current (within twelve months) problem with alcohol or drug abuse, is currently enrolled in an investigational drug or device study or has participated in such a study within the last 30 days.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Size of myoma. Timepoint: 12 weeks after microrelin subscription. Method of measurement: sonography.
Secondary Outcome Measures
NameTimeMethod
evel of gonadotrophins and estrogen in serum. Timepoint: two and 12 weeks after microrelin subscription. Method of measurement: ELISA.;Surgeon's satisfaction. Timepoint: end of operation. Method of measurement: Visual Assessment Score.;Operation time. Timepoint: end of operation. Method of measurement: surjeon's announcement.;Absorbed fluide volume. Timepoint: end of operation. Method of measurement: fluide gathered in suction subtracted from used fluide.
© Copyright 2025. All Rights Reserved by MedPath